Alex Voda | Pharma R&D and Longevity
This episode is sponsored by Talkatoo.
Save hours on notes.
Talkatoo gives vets their time back — now $1 for full access to Talkatoo for your first month!
In This Episode
In this episode of the Veterinary Innovation Podcast, Shawn Wilkie and Dr. Ivan Zak are joined by Alex Voda from The Cat Health Company to explore how pharmaceutical R&D and longevity research can solve some of the toughest challenges in veterinary medicine. With limited options for aging cats suffering from chronic diseases like CKD and diabetes, veterinarians often struggle to offer more than palliative care. Alex shares why cats are uniquely positioned as models for longevity research and how new therapeutics could extend both lifespan and healthspan.
The conversation highlights how veterinary medicine has historically driven drug innovation, why longevity companies are moving slowly, and how The Cat Health Company has accelerated to clinical-stage status far quicker than expected. Alex also predicts the potential impact for veterinary practices — more effective consultations, longer patient lifespans, and new treatment pathways that could redefine how clinics approach feline health.
Learn more about The Cat Health Company.
Alex recommends Youtube – Alex Zhavoronkov at ARDD2024: Methylation Clocks and AI Life Models as Sources of Therapeutic Target.
Topics Covered
- Veterinary-first drug innovation
- Longevity research challenges
- Cats as a pharma model